Astellas Pharma Overview
Astellas Pharma Discounted Cash Flow
DCF Analysis for ALPMY.
Get informed when a big investor buys or sells
+ FollowFair Value
$48.53
Current Fair Value
$48.53
↑ 260.8% Upside
Undervalued by 260.8% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison